Gotham Asset Management LLC bought a new stake in Imperva Inc (NYSE:IMPV) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,709 shares of the software maker’s stock, valued at approximately $358,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of IMPV. Russell Investments Group Ltd. acquired a new position in Imperva during the fourth quarter worth $1,659,000. State Street Corp raised its position in Imperva by 6.3% in the fourth quarter. State Street Corp now owns 519,143 shares of the software maker’s stock worth $19,937,000 after buying an additional 30,720 shares during the period. A.R.T. Advisors LLC acquired a new position in Imperva during the fourth quarter worth $288,000. First Republic Investment Management Inc. raised its position in Imperva by 6.7% in the fourth quarter. First Republic Investment Management Inc. now owns 7,185 shares of the software maker’s stock worth $276,000 after buying an additional 453 shares during the period. Finally, Norges Bank acquired a new position in Imperva during the fourth quarter worth $964,000. 92.72% of the stock is currently owned by institutional investors and hedge funds.
Shares of Imperva Inc (NYSE IMPV) traded down 0.34% during midday trading on Friday, reaching $43.90. 548,485 shares of the company’s stock traded hands. The stock’s 50-day moving average price is $48.73 and its 200 day moving average price is $45.22. Imperva Inc has a one year low of $34.40 and a one year high of $57.24. The firm’s market capitalization is $1.48 billion.
Imperva (NYSE:IMPV) last announced its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by $0.15. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The business had revenue of $74.44 million during the quarter, compared to analyst estimates of $74.30 million. During the same period last year, the company earned ($0.23) EPS. The business’s revenue for the quarter was up 28.6% on a year-over-year basis. On average, equities research analysts expect that Imperva Inc will post $0.81 earnings per share for the current fiscal year.
A number of research analysts recently weighed in on the stock. UBS AG assumed coverage on shares of Imperva in a research report on Tuesday, June 6th. They set a “positive” rating and a $60.00 price target on the stock. BidaskClub lowered shares of Imperva from a “buy” rating to a “hold” rating in a research report on Tuesday, July 25th. Zacks Investment Research raised shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $52.00 price target on the stock in a research report on Wednesday. Monness Crespi & Hardt raised their price target on shares of Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Finally, Stifel Nicolaus restated a “hold” rating and set a $47.00 price objective on shares of Imperva in a report on Friday, July 14th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $51.25.
In related news, CRO Michael D. Mooney sold 52,356 shares of the stock in a transaction dated Wednesday, May 10th. The stock was sold at an average price of $47.51, for a total transaction of $2,487,433.56. Following the transaction, the executive now owns 52,356 shares of the company’s stock, valued at approximately $2,487,433.56. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Sunil D. Nagdev sold 4,857 shares of the stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $49.00, for a total value of $237,993.00. Following the transaction, the senior vice president now directly owns 16,290 shares in the company, valued at approximately $798,210. The disclosure for this sale can be found here. In the last ninety days, insiders sold 60,302 shares of company stock worth $2,875,861. Corporate insiders own 2.20% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with our FREE daily email newsletter.